Julius Knowles - Profile and Investment Details

Investor Profile

Julius Knowles is a Venture Capital, Design Operator, Strategy Operator, Private Equity Firm, Finance Operator based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance, ZielBio, TargAnox, Editas MedicineLysosomal Therapeutics, Pykus Therapeutics, Annovation BioPharma, Vertex Pharmaceuticals, Abcuro, Nocion Therapeutics, Translate Bio, Sebacia, ROME Therapeutics, Daktari Diagnostics, SwanBio Therapeutics, Raze Therapeutics, lifeIMAGE, Keros Therapeutics, Spero Therapeutics, Alizé Pharma, Akouos, Syntimmune, Triplet Therapeutics, Affinia Therapeutics, QPID Health, . Over time, Julius Knowles has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Julius Knowles is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Women Founded, HR Tech, Design, Creative Strategy, AngularJS, Life Science, Banking, Surf Tech, Finance, Biotechnology, Electronic Health Records (EHR), ServiceNow Development, Marine Technology, Web Development, Health Diagnostics, Innovation Management, Digital Health, Medical, Therapeutics, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Julius Knowles, as their portfolio suggests a familiarity and interest in this area.

Understanding Julius Knowles’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.